文献速递疼痛医学

高剂量纳洛酮揭示潜在敏化的药代动力学研究

High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans.
PubMed 文献 · Br J Anaesth · 2019-01-18

本研究在8名健康志愿者中给予三阶段阶梯式高剂量静脉纳洛酮输注(总剂量3.25 mg kg-1),建立纳洛酮及其主要代谢物N3G的群体药代动力学模型。结果显示纳洛酮为三室模型、N3G为二室模型,均呈线性消除,未观察到饱和动力学;Yassen模型预测准确,而Dowling模型高估纳洛酮浓度。

要点

  • 高剂量纳洛酮输注呈线性消除,未观察到饱和药代动力学。
  • Yassen模型能准确预测纳洛酮药代动力学,Dowling模型不准确且高估浓度。
  • 新协变量模型可用于实验和临床高剂量靶控输注纳洛酮。

核心结论

  • 高剂量纳洛酮输注后纳洛酮与N3G呈线性消除,未观察到饱和药代动力学。
  • Dowling模型不准确且高估纳洛酮浓度,Yassen模型能准确预测纳洛酮药代动力学。
  • 新开发的协变量模型可用于实验和临床高剂量靶控输注纳洛酮。

研究设计与样本

  • 8名健康志愿者接受三阶段阶梯式高剂量静脉纳洛酮输注,总剂量3.25 mg kg-1。
  • 从输注开始至输注停止后334 min采样纳洛酮和N3G血浆浓度。
  • 采用非线性混合效应模型(NONMEM)进行药代动力学分析,并评估Dowling与Yassen模型的预测性能及靶控输注模拟。

主要发现

  • 纳洛酮浓度时间过程用三室处置模型描述,N3G用二室模型描述,均为线性消除动力学。
  • 开发了简单(体重比例)和复杂(浅外周分布容积随体重线性增加)两种协变量模型。
  • Dowling模型的中位预测误差(MDPE)为-32.5%,wobble为33.4%;Yassen模型的MDPE为1.2%,wobble为19.9%。

临床怎么用

  • 在高剂量纳洛酮实验或临床靶控输注中,可优先参考Yassen模型进行药代动力学预测。
  • 新开发的协变量模型可用于高剂量靶控输注纳洛酮的实验和临床实践。

局限性

  • 研究仅纳入8名健康志愿者,样本量小。
  • 研究为高剂量静脉输注条件下的药代动力学描述,未涉及临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Naloxone, an opioid receptor antagonist, is used as a pharmacological tool to detect tonic endogenous activation of opioid receptors in experimental pain models. We describe a pharmacokinetic model linking naloxone pharmacokinetics to its main metabolite after high-dose naloxone infusion. METHODS: Eight healthy volunteers received a three-stage stepwise high-dose i.v. naloxone infusion (total dose 3.25 mg kg-1). Naloxone and naloxone-3-glucuronide (N3G) plasma concentrations were sampled from infusion onset to 334 min after infusion discontinuation. Pharmacokinetic analysis was performed using non-linear mixed effect models (NONMEM). The predictive performances of Dowling's and Yassen's models were evaluated, and target-controlled infusion simulations were performed. RESULTS: Three- and two-compartment disposition models with linear elimination kinetics described the naloxone and N3G concentration time-courses, respectively. Two covariate models were developed: simple (weight proportional) and complex (with the shallow peripheral volume of distribution linearly increasing with body weight). The median prediction error (MDPE) and wobble for Dowling's model were -32.5% and 33.4%, respectively. For Yassen's model, the MDPE and wobble were 1.2% and 19.9%, respectively. CONCLUSIONS: A parent-metabolite pharmacokinetic model was developed for naloxone and N3G after high-dose naloxone infusion. No saturable pharmacokinetics were observed. Whereas Dowling's model was inaccurate and over-predicted naloxone concentrations, Yassen's model accurately predicted naloxone pharmacokinetics. The newly developed covariate models may be used for high-dose TCI-naloxone for experimental and clinical practice. CLINICAL TRIALS REGISTRATION: NCT01992146.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Papathanasiou T, Springborg AD, Kongstad KT, et al. High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans. Br J Anaesth. 2019. PMID: 30915992. doi:10.1016/j.bja.2018.12.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。